Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance-Reference-Cited by-同舟云学术

Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance

Published:2013-05-01 Issue:6 Volume:123 Page:2509-2522
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Hopewell Emily L.,Zhao Weipeng,Fulp William J.,Bronk Crystina C.,Lopez Alexis S.,Massengill Michael,Antonia Scott,Celis Esteban,Haura Eric B.,Enkemann Steven A.,Chen Dung-Tsa,Beg Amer A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference84 articles.

1. Epidermal growth factor receptor mutations in lung cancer

2. Targeting RAS signalling pathways in cancer therapy

3. Targeting RAS and PI3K in lung cancer

4. Crizotinib

5. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker;Breast Cancer: Targets and Therapy;2024-07

2. An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma;ESMO Open;2024-05

3. UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity;Molecular Cell;2024-03

4. Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma;Cell Death & Disease;2024-02-19

5. Nuclear factor kappa B expression in non-small cell lung cancer;Biomedicine & Pharmacotherapy;2023-11